HK Stock MarketDetailed Quotes

02170 BASECARE-B

Watchlist
  • 3.000
  • +0.170+6.01%
Market Closed Dec 12 16:08 CST
820.58MMarket Cap-2.99P/E (TTM)

BASECARE-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(Q6)Jun 30, 2020
Cash flow from operating activities
Earning before tax
----
-67.58%-196.32M
----
6.84%-117.15M
----
85.80%-125.75M
----
-65.09%-885.35M
-128.15%-856.56M
----
Profit adjustment
Interest (income) - adjustment
----
-62.94%-38.51M
----
-29.84%-23.63M
----
-3,387.16%-18.2M
----
-635.21%-522K
-318.97%-243K
----
Attributable subsidiary (profit) loss
----
----
----
----
----
----
----
-428.95%-250K
-428.95%-250K
----
Revaluation surplus:
----
170.73%2.4M
----
---3.4M
----
----
----
88.49%-120K
80.89%-120K
----
-Other fair value changes
----
170.73%2.4M
----
---3.4M
----
----
----
88.49%-120K
80.89%-120K
----
Asset sale loss (gain):
----
102.06%179K
----
-869,600.00%-8.7M
----
-100.17%-1K
----
--602K
--1.73M
----
-Loss (gain) from sale of subsidiary company
----
----
----
---8.76M
----
----
----
--1.56M
--1.56M
----
-Loss (gain) on sale of property, machinery and equipment
----
179.69%179K
----
6,500.00%64K
----
99.90%-1K
----
---953K
--177K
----
Depreciation and amortization:
----
133.30%19.57M
----
50.14%8.39M
----
-16.90%5.59M
----
-19.71%6.72M
-9.00%5.54M
----
-Amortization of intangible assets
----
18,532.26%5.78M
----
--31K
----
----
----
----
----
----
Financial expense
----
395.26%2.61M
----
-58.17%527K
----
-15.32%1.26M
----
9.09%1.49M
19.65%1.17M
----
Exchange Loss (gain)
----
81.15%-11.86M
----
-710.31%-62.91M
----
20.51%10.31M
----
--8.55M
----
----
Special items
----
----
----
----
----
-99.04%7.91M
----
58.87%826.83M
128.07%826.83M
----
Operating profit before the change of operating capital
----
-7.28%-221.92M
----
-74.00%-206.87M
----
-182.73%-118.89M
----
-488.88%-42.05M
-239.53%-21.9M
----
Change of operating capital
Inventory (increase) decrease
----
-43.52%-21.15M
----
38.84%-14.74M
----
-683.77%-24.1M
----
210.05%4.13M
180.63%1.85M
----
Accounts receivable (increase)decrease
----
114.21%2.14M
----
67.86%-15.07M
----
-3.39%-46.89M
----
-186.76%-45.35M
7.26%-42.83M
----
Accounts payable increase (decrease)
----
-174.19%-22.39M
----
289.29%30.18M
----
-59.16%7.75M
----
265.96%18.98M
-23.59%15.78M
----
Special items for working capital changes
----
-103.64%-646K
----
212.70%17.73M
----
---15.73M
----
----
----
----
Cash  from business operations
-1.81%-122.31M
-39.84%-263.97M
-31.10%-120.14M
4.59%-188.77M
-29.59%-91.64M
-207.76%-197.85M
-156.87%-70.72M
-68.54%-64.29M
-37.43%-47.1M
-260.16%-27.53M
Other taxs
102.28%71K
---3.26M
---3.12M
----
----
----
----
----
----
----
Net cash from operations
0.82%-122.24M
-41.57%-267.23M
-34.50%-123.26M
4.59%-188.77M
-29.59%-91.64M
-207.76%-197.85M
-156.87%-70.72M
-68.54%-64.29M
-37.43%-47.1M
-260.16%-27.53M
Cash flow from investment activities
Interest received - investment
-38.62%14.5M
97.17%41.21M
245.74%23.63M
20.96%20.9M
10.33%6.83M
3,209.96%17.28M
4,142.47%6.19M
635.21%522K
318.97%243K
305.56%146K
Loan receivable (increase) decrease
----
----
----
----
----
200.00%5.1M
440.00%5.1M
---5.1M
--0
---1.5M
Decrease in deposits (increase)
---70M
----
----
----
----
----
----
----
----
----
Sale of fixed assets
-97.11%10K
1,042.86%880K
27.21%346K
-78.37%77K
--272K
189.43%356K
----
--123K
--352K
--228K
Purchase of fixed assets
-9.07%-55.4M
18.87%-104.21M
19.63%-50.79M
-344.47%-128.45M
-912.04%-63.19M
-257.36%-28.9M
-109.74%-6.24M
-242.52%-8.09M
-167.57%-4.94M
-108.04%-2.98M
Purchase of intangible assets
----
----
----
96.24%-299K
33.44%-5.3M
---7.96M
---7.96M
----
----
----
Sale of subsidiaries
----
-106.04%-3.24M
----
--53.6M
----
----
----
--15.4M
--899K
---1.84M
Acquisition of subsidiaries
----
-693.20%-257.89M
-682.75%-254.49M
---32.51M
---32.51M
----
----
----
----
----
Recovery of cash from investments
----
----
----
--75.41M
----
----
----
-73.74%60.68M
-59.45%60.68M
-33.72%60.68M
Cash on investment
72.84%-427K
97.97%-1.57M
93.71%-1.57M
---77.43M
---25M
----
----
85.85%-30M
78.87%-30M
26.83%-30M
Other items in the investment business
----
----
----
----
----
---42.48M
----
----
----
----
Net cash from investment operations
60.65%-111.31M
-266.20%-324.81M
-137.92%-282.88M
-56.70%-88.7M
-3,985.77%-118.9M
-268.79%-56.6M
-111.76%-2.91M
100.02%33.53M
365.29%27.23M
-49.68%24.74M
Net cash before financing
42.49%-233.55M
-113.38%-592.05M
-92.90%-406.13M
-9.04%-277.47M
-185.95%-210.54M
-727.39%-254.46M
-2,535.22%-73.63M
-43.84%-30.75M
30.08%-19.87M
-106.73%-2.79M
Cash flow from financing activities
New borrowing
-53.82%67.29M
295.46%196.74M
516.21%145.7M
13.99%49.75M
18.23%23.65M
45.48%43.65M
0.00%20M
0.00%30M
20.00%30M
--20M
Refund
---9.11M
----
----
33.33%-20M
33.33%-20M
0.00%-30M
-50.00%-30M
-50.00%-30M
-50.00%-30M
---20M
Issuing shares
----
----
----
----
----
--1.68B
--1.58B
----
----
----
Interest paid - financing
-78.57%-250K
-25.26%-238K
-23.89%-140K
19.83%-190K
10.32%-113K
-146.88%-237K
-121.05%-126K
12.73%-96K
14.13%-79K
14.93%-57K
Absorb investment income
----
--5.1M
--5.1M
----
----
----
----
--211.67M
--211.67M
----
Issuance expenses and redemption of securities expenses
----
----
----
----
----
-477.82%-92.44M
----
---16M
---2.72M
----
Other items of the financing business
-360.49%-5.62M
-116.37%-6.26M
8.48%-1.22M
-184.94%-2.9M
-129.43%-1.33M
-107.47%-1.02M
-104.08%-581K
-27.69%13.6M
-27.33%13.92M
2,605.27%14.26M
Net cash from financing operations
-66.05%49.87M
710.37%190.55M
63,771.30%146.9M
-98.53%23.51M
-99.99%230K
669.08%1.6B
11,888.57%1.57B
683.09%207.47M
886.24%221.13M
861.16%13.09M
Effect of rate
-79.07%5.28M
-80.02%12.57M
-29.78%25.24M
710.31%62.91M
3,556.54%35.95M
-20.51%-10.31M
---1.04M
---8.55M
----
----
Net Cash
29.14%-183.68M
-58.10%-401.5M
-23.26%-259.23M
-118.94%-253.95M
-114.06%-210.31M
658.93%1.34B
14,426.27%1.5B
3,355.59%176.72M
3,453.07%201.25M
-74.12%10.3M
Begining period cash
-29.20%943.22M
-12.54%1.33B
-12.54%1.33B
692.01%1.52B
692.01%1.52B
696.20%192.32M
696.20%192.32M
26.86%24.16M
26.86%24.16M
26.86%24.16M
Cash at the end
-30.35%764.82M
-29.20%943.22M
-18.58%1.1B
-12.54%1.33B
-20.05%1.35B
692.01%1.52B
4,797.09%1.69B
696.20%192.32M
1,628.71%225.41M
-41.44%34.45M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
--
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(Q6)Jun 30, 2020
Cash flow from operating activities
Earning before tax -----67.58%-196.32M----6.84%-117.15M----85.80%-125.75M-----65.09%-885.35M-128.15%-856.56M----
Profit adjustment
Interest (income) - adjustment -----62.94%-38.51M-----29.84%-23.63M-----3,387.16%-18.2M-----635.21%-522K-318.97%-243K----
Attributable subsidiary (profit) loss -----------------------------428.95%-250K-428.95%-250K----
Revaluation surplus: ----170.73%2.4M-------3.4M------------88.49%-120K80.89%-120K----
-Other fair value changes ----170.73%2.4M-------3.4M------------88.49%-120K80.89%-120K----
Asset sale loss (gain): ----102.06%179K-----869,600.00%-8.7M-----100.17%-1K------602K--1.73M----
-Loss (gain) from sale of subsidiary company ---------------8.76M--------------1.56M--1.56M----
-Loss (gain) on sale of property, machinery and equipment ----179.69%179K----6,500.00%64K----99.90%-1K-------953K--177K----
Depreciation and amortization: ----133.30%19.57M----50.14%8.39M-----16.90%5.59M-----19.71%6.72M-9.00%5.54M----
-Amortization of intangible assets ----18,532.26%5.78M------31K------------------------
Financial expense ----395.26%2.61M-----58.17%527K-----15.32%1.26M----9.09%1.49M19.65%1.17M----
Exchange Loss (gain) ----81.15%-11.86M-----710.31%-62.91M----20.51%10.31M------8.55M--------
Special items ---------------------99.04%7.91M----58.87%826.83M128.07%826.83M----
Operating profit before the change of operating capital -----7.28%-221.92M-----74.00%-206.87M-----182.73%-118.89M-----488.88%-42.05M-239.53%-21.9M----
Change of operating capital
Inventory (increase) decrease -----43.52%-21.15M----38.84%-14.74M-----683.77%-24.1M----210.05%4.13M180.63%1.85M----
Accounts receivable (increase)decrease ----114.21%2.14M----67.86%-15.07M-----3.39%-46.89M-----186.76%-45.35M7.26%-42.83M----
Accounts payable increase (decrease) -----174.19%-22.39M----289.29%30.18M-----59.16%7.75M----265.96%18.98M-23.59%15.78M----
Special items for working capital changes -----103.64%-646K----212.70%17.73M-------15.73M----------------
Cash  from business operations -1.81%-122.31M-39.84%-263.97M-31.10%-120.14M4.59%-188.77M-29.59%-91.64M-207.76%-197.85M-156.87%-70.72M-68.54%-64.29M-37.43%-47.1M-260.16%-27.53M
Other taxs 102.28%71K---3.26M---3.12M----------------------------
Net cash from operations 0.82%-122.24M-41.57%-267.23M-34.50%-123.26M4.59%-188.77M-29.59%-91.64M-207.76%-197.85M-156.87%-70.72M-68.54%-64.29M-37.43%-47.1M-260.16%-27.53M
Cash flow from investment activities
Interest received - investment -38.62%14.5M97.17%41.21M245.74%23.63M20.96%20.9M10.33%6.83M3,209.96%17.28M4,142.47%6.19M635.21%522K318.97%243K305.56%146K
Loan receivable (increase) decrease --------------------200.00%5.1M440.00%5.1M---5.1M--0---1.5M
Decrease in deposits (increase) ---70M------------------------------------
Sale of fixed assets -97.11%10K1,042.86%880K27.21%346K-78.37%77K--272K189.43%356K------123K--352K--228K
Purchase of fixed assets -9.07%-55.4M18.87%-104.21M19.63%-50.79M-344.47%-128.45M-912.04%-63.19M-257.36%-28.9M-109.74%-6.24M-242.52%-8.09M-167.57%-4.94M-108.04%-2.98M
Purchase of intangible assets ------------96.24%-299K33.44%-5.3M---7.96M---7.96M------------
Sale of subsidiaries -----106.04%-3.24M------53.6M--------------15.4M--899K---1.84M
Acquisition of subsidiaries -----693.20%-257.89M-682.75%-254.49M---32.51M---32.51M--------------------
Recovery of cash from investments --------------75.41M-------------73.74%60.68M-59.45%60.68M-33.72%60.68M
Cash on investment 72.84%-427K97.97%-1.57M93.71%-1.57M---77.43M---25M--------85.85%-30M78.87%-30M26.83%-30M
Other items in the investment business -----------------------42.48M----------------
Net cash from investment operations 60.65%-111.31M-266.20%-324.81M-137.92%-282.88M-56.70%-88.7M-3,985.77%-118.9M-268.79%-56.6M-111.76%-2.91M100.02%33.53M365.29%27.23M-49.68%24.74M
Net cash before financing 42.49%-233.55M-113.38%-592.05M-92.90%-406.13M-9.04%-277.47M-185.95%-210.54M-727.39%-254.46M-2,535.22%-73.63M-43.84%-30.75M30.08%-19.87M-106.73%-2.79M
Cash flow from financing activities
New borrowing -53.82%67.29M295.46%196.74M516.21%145.7M13.99%49.75M18.23%23.65M45.48%43.65M0.00%20M0.00%30M20.00%30M--20M
Refund ---9.11M--------33.33%-20M33.33%-20M0.00%-30M-50.00%-30M-50.00%-30M-50.00%-30M---20M
Issuing shares ----------------------1.68B--1.58B------------
Interest paid - financing -78.57%-250K-25.26%-238K-23.89%-140K19.83%-190K10.32%-113K-146.88%-237K-121.05%-126K12.73%-96K14.13%-79K14.93%-57K
Absorb investment income ------5.1M--5.1M------------------211.67M--211.67M----
Issuance expenses and redemption of securities expenses ---------------------477.82%-92.44M-------16M---2.72M----
Other items of the financing business -360.49%-5.62M-116.37%-6.26M8.48%-1.22M-184.94%-2.9M-129.43%-1.33M-107.47%-1.02M-104.08%-581K-27.69%13.6M-27.33%13.92M2,605.27%14.26M
Net cash from financing operations -66.05%49.87M710.37%190.55M63,771.30%146.9M-98.53%23.51M-99.99%230K669.08%1.6B11,888.57%1.57B683.09%207.47M886.24%221.13M861.16%13.09M
Effect of rate -79.07%5.28M-80.02%12.57M-29.78%25.24M710.31%62.91M3,556.54%35.95M-20.51%-10.31M---1.04M---8.55M--------
Net Cash 29.14%-183.68M-58.10%-401.5M-23.26%-259.23M-118.94%-253.95M-114.06%-210.31M658.93%1.34B14,426.27%1.5B3,355.59%176.72M3,453.07%201.25M-74.12%10.3M
Begining period cash -29.20%943.22M-12.54%1.33B-12.54%1.33B692.01%1.52B692.01%1.52B696.20%192.32M696.20%192.32M26.86%24.16M26.86%24.16M26.86%24.16M
Cash at the end -30.35%764.82M-29.20%943.22M-18.58%1.1B-12.54%1.33B-20.05%1.35B692.01%1.52B4,797.09%1.69B696.20%192.32M1,628.71%225.41M-41.44%34.45M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion----
Auditor --KPMG--KPMG--KPMG--KPMG----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-0.85%